AzTrials
AzTrials

Chronic Low-back PainNCT06814470

Virtual Reality Guided Acupuncture Imagery Treatment for Chronic Low Back Pain

A study testing Virtual reality guided imagery acupuncture treatment (VRGAIT) in people with Chronic Low-back Pain, run by Massachusetts General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Testing the effect of Virtual Reality - guided imagery acupuncture Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Virtual reality guided imagery acupuncture treatment (VRGAIT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteUnited States
Study dates
16 Jul 2024to 31 Aug 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Volunteers 18-75 years of age.
  • Meet the Classification Criteria of chronic LBP (having low back pain for more than 6 months), as determined by the referring physician.
  • At least 4/10 clinical pain on the 11-point LBP intensity scale.
  • Must have had a prior evaluation of their low back pain by a health care provider, which may have included radiographic studies. Documentation of this evaluation will be sought from Partners or outside medical records and kept in the subject's research record.
  • At least a 10th grade English-reading level; English can be a second language provided that the patients feel they understand all the questions used in the assessment measures.

Who cannot join

  • Specific causes of back pain (e.g. cancer, fractures, infections),
  • Complicated back problems (e.g. prior back surgery, medico legal issues),
  • Possible contraindications for acupuncture (e.g. coagulation disorders, cardiac pacemakers, pregnancy, seizure disorder), and conditions that might confound longitudinal effects or interpretation of results (e.g. severe fibromyalgia, rheumatoid arthritis).
  • Conditions making study participation difficult (eg, paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1)
  • The intent to undergo surgery during the time of involvement in the study.
  • Unresolved medical legal/disability/workers compensation claims in connection with low back pain.
  • Lacking the capacity to consent for oneself
  • Do not have access to zoom or other software regularly to complete the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Lucy Chen

    Charlestown, Massachusetts, 02129

Other trials in United States

About this study

Official title: A Feasibility Study of Virtual Reality Guided Acupuncture Imagery Treatment for Chronic Low Back Pain

Testing the effect of Virtual Reality - guided imagery acupuncture

Read the detailed description

The aim of this study is to develop a Virtual Reality guided acupuncture imagery treatment system for the treatment of chronic low back pain. This product will provide a new cost-effective treatment option for chronic low back pain and potentially other chronic pain disorders.

Being tested
Virtual reality guided imagery acupuncture treatment (VRGAIT), Virtual reality guided imagery acupuncture treatment control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual reality guided imagery acupuncture treatment (VRGAIT)Other

    Subject watching Virtual reality video of acupuncture needle stimulation

  • Virtual reality guided imagery acupuncture treatment controlOther

    Subject watching VR video of swab touching

Study groups in NCT06814470
Study groupRoleWhat they receive
Virtual Reality - guided acupuncture imagery treatment (VRGAIT)ExperimentalNot described
Receives: Other: Virtual reality guided imagery acupuncture treatment (VRGAIT)
Virtual Reality -guided acupuncture imagery treatment (VRGAIT) ControlActive comparatorNot described
Receives: Other: Virtual reality guided imagery acupuncture treatment control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Retention

    Proportion of subjects who complete all assessments from the total number of subjects who were enrolled in the study

    Measured: Through study intervention, an average of about four weeks

  2. Satisfaction to the Interventions

    Mean of the satisfaction score on a scale from 1 to 5, larger number indicated greater satisfaction. Assessed after each study interventions, an average score is reported.,

    Measured: up to 4 weeks

  3. Number of Adverse Events (Safety of the Intervention)

    Symptoms and adverse events reported by the participants

    Measured: Through study interventions, an average of about four weeks

Secondary outcomes (4)
  1. PROMIS-29

    The PROMIS-29 profile measure assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items for each domain. We use pain intensity in this report, low score indicates improvement.

    Measured: baseline, midpoint (week 2), and post-treatment (week 4), the change of score (baseline minus post-treatment) is reported.

  2. Pain Bothersomeness Scale

    This is a self-reported measure of cLBP pain severity that is commonly used to assess clinical chronic pain. Participants rate how bothersome their LBP was during the previous week with a VAS scale (0-10) from "not at all bothersome" (0) to "extremely bothersome" (10).

    Measured: baseline, midpoint (week 2), and post-treatment (week 4), the change of score (baseline minus post-treatment) is reported.

  3. MGH Acupuncture Sensation Scale (MASS)

    MASS is a scale developed to measure sensations evoked by acupuncture treatment (total range 0-120). The MASS will be applied after each treatment. We reported total score in this report (average of sum of each session). larger numbers indicate stronger sensations.

    Measured: up to 4 weeks.

  4. Vividness Scale

    Vividness Scale is a 0-10 vividness scale to measure imagery vividness during the intervention. The scale ranges from Not Vivid/Unclear (0) to Vivid/Clear (10).

    Measured: After each study interventions, the average score is reported.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2025
  2. Study start16 Jul 2024
  3. Primary completion3 Jan 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
subject will be randomized to 2 groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06814470
Sponsor's protocol ID
2018p002553-1
Status last verified
Nov 2024
First submitted
28 Jan 2025
Last updated
26 Jan 2026
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The Small Business Act permits NIH SBIR/STTR grantees to withhold data for 4 years after the end of the grant award.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual reality guided imagery acupuncture treatment (VRGAIT) in people with Chronic Low-back Pain, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Jan 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Retention (time frame: Through study intervention, an average of about four weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in